Wei‐Chun HuangFu

1.0k citations
43 papers · 847 indexed · h-index 18
Topics
Histone Deacetylase Inhibitors Research (8 papers)Ubiquitin and proteasome pathways (5 papers)Proteoglycans and glycosaminoglycans research (4 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Wei‐Chun HuangFu

40 papers receiving 844 citations

Peers

Wei‐Chun HuangFu
Comparison fields: 5 of 93
  • Molecular Biology 459
  • Immunology 184
  • Oncology 173
  • Organic Chemistry 88
  • Epidemiology 85
Replace Halime Kalkavan with:
Halime Kalkavan United States
Sheng‐Tao Cheng China
Kheewoong Baek United States
Marc Germain Canada
Maria Anele Romeo Italy
Chunlai Nie China
Xianxi Wang United States
Daniel Grasso Argentina
Gabriela Galicia-Vázquez Canada
Barbara Saxty United Kingdom
Wei‐Chun HuangFu relative to Halime Kalkavan United States Halime Kalkavan's profile →
Citations per field
00.5×5.5×
Halime Kalkavan · 1×
Citations per year

Countries citing papers authored by Wei‐Chun HuangFu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chun HuangFu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chun HuangFu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chun HuangFu more than expected).

Fields of papers citing papers by Wei‐Chun HuangFu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chun HuangFu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chun HuangFu. The network helps show where Wei‐Chun HuangFu may publish in the future.

Co-authorship network of co-authors of Wei‐Chun HuangFu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chun HuangFu. A scholar is included among the top collaborators of Wei‐Chun HuangFu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chun HuangFu. Wei‐Chun HuangFu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 2
4 1
5 0
6 3
7 7
8 11
9 8
10 4
11 17
12 6
13 63
14 26
15 9
16 35
17 18
18 40
19 39
20 38

About Wei‐Chun HuangFu

Wei‐Chun HuangFu is a scholar working on Geriatrics and Gerontology, Cell Biology and Molecular Biology, having authored 43 papers that have together received 847 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Ubiquitin and proteasome pathways (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). The work is most often cited by research in Geriatrics and Gerontology (45 citations), Immunology (184 citations) and Toxicology (23 citations). Wei‐Chun HuangFu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Serge Y. Fuchs, Shiow‐Lin Pan, Kai‐Cheng Hsu, Jianghuai Liu, Tony Eight Lin, Juan Qian, Jing‐Ping Liou, Han-Li Huang, Min‐Wu Chao and I‐Hsuan Liu. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026